| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Sublingual Immunotherapy |
| Brand | Grazax® |
| Indication | For the Prevention of Seasonal Grass Pollen-Induced Rhinoconjunctivitis. |
| Assessment Process | |
| Rapid review commissioned | 01/09/2007 |
| Rapid review completed | 24/09/2007 |
| Rapid review outcome | Reimbursement not recommended |
The cost-effectiveness of Grazax® remains to be established and this product cannot be recommended as value for money at this point in time.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
